MarketVibe - S&P 500 Business Analysis | Business Investing

Discover how a 1960s discount store became a trillion-dollar healthcare giant controlling your insurance, prescriptions, and clinics.

[INTRO]

ALEX: In 2014, one of the largest retailers in the world decided to light 2 billion dollars on fire. Not literally, but they voluntarily stopped selling tobacco products across thousands of stores because cigarettes didn't fit their new identity as a healthcare company.

JORDAN: Wait, 2 billion dollars in annual revenue? Just walked away from it? That sounds like a massive gamble for a pharmacy chain.

ALEX: It wasn't just a pharmacy chain anymore. That move signaled the birth of CVS Health—a company that has transitioned from a simple corner store into a vertically integrated behemoth that likely touches almost every part of your medical life.

JORDAN: So they aren't just the place where I get my long receipts and some overpriced toothpaste? What are they now?

[CHAPTER 1 - Origin]

ALEX: It started way back in 1963 in Lowell, Massachusetts. Three guys—Stanley and Sidney Goldstein and Ralph Hoagland—opened the first "Consumer Value Store."

JORDAN: CVS stands for Consumer Value Store? I always wondered about that. Was it even a pharmacy back then?

ALEX: Not at all. It was a discount health and beauty store. They didn't even add the actual pharmacy counter until four years later.

JORDAN: So they were basically a localized Sephora or Walgreens competitor that just happened to scale up?

ALEX: Exactly. They were acquired by a parent company called Melville Corporation in 1969, which gave them the cash to start gobbling up other chains. By the 90s, they were buying competitors like Revco and Peoples Drug, slowly becoming the dominant name in the suburbs.

JORDAN: Okay, but lots of companies grow by buying rivals. Most of those just remain big stores. When did they turn into this "healthcare empire" you're talking about?

[CHAPTER 2 - Core Story]

ALEX: The shift happened when they stopped looking at themselves as a shop and started looking at themselves as a system. In 2006, they bought MinuteClinic, which pioneered the idea of seeing a nurse at the mall instead of a doctor in an office.

JORDAN: I remember those. It felt weird at first, like getting a check-up at a gas station. But it was fast.

ALEX: Efficiency was the goal, but the real power move came in 2007. They merged with Caremark Rx. This made them a Pharmacy Benefit Manager, or PBM.

JORDAN: Hold on, I hear that term on the news all the time. What does a PBM actually do?

ALEX: They are the middlemen. They decide which drugs your insurance will cover and negotiate the prices with the manufacturers. Suddenly, CVS wasn't just selling you the pills; they were the ones deciding which pills you were allowed to buy and what your employer would pay for them.

JORDAN: That sounds like a huge conflict of interest. They’re the store and the person deciding what the store stocks?

ALEX: Critics said exactly that. But CVS doubled down. In 2018, they pulled off their biggest move yet: they bought Aetna, one of the biggest health insurance companies in America, for 70 billion dollars.

JORDAN: So now they own the insurance company that pays for the medicine, the middleman who picks the medicine, and the pharmacy that sells the medicine? That's the "vertical integration" everyone talks about.

ALEX: It is. They even went further recently, buying Oak Street Health and Signify Health to own the doctors' offices and home-care visits too. They want to be the "front door" to healthcare.

JORDAN: But there’s a dark side to being that big, right? I've seen the headlines about the opioid crisis.

ALEX: Yes, the scale came with massive legal baggage. In 2022, CVS agreed to pay 5 billion dollars to settle lawsuits claiming they didn't do enough to stop the flood of opioid prescriptions. They also faced a record 77 million dollar fine for pseudoephedrine sales used to make meth.

JORDAN: It sounds like they were moving so fast to dominate the market that the actual "health" part of CVS Health got messy.

ALEX: And the people on the front lines feel it. Many CVS pharmacists have protested recently, claiming that understaffing and high quotas for things like vaccines make their jobs dangerous for patients.

[CHAPTER 3 - Why It Matters]

JORDAN: So, looking at them today, are they actually making healthcare cheaper or just making themselves richer?

ALEX: That’s the multi-billion dollar question. CVS argues that by owning the whole chain, they can coordinate care better and lower costs. If you have Aetna insurance, they can nudge you toward a CVS HealthHUB for a cheaper check-up, which keeps you out of the expensive ER.

JORDAN: But if you’re a small independent pharmacy, you're basically being squeezed out by a giant that controls your reimbursement rates.

ALEX: Exactly. They’ve become a lightning rod for antitrust discussions. Yet, they are so integrated into the American infrastructure that it’s almost impossible to avoid them. They have over 9,000 locations. Most Americans live within a few miles of a CVS.

JORDAN: It’s wild that a discount beauty shop from the 60s now has the power to influence the national price of insulin.

ALEX: They’ve even moved into your pop culture. Remember the "CVS receipt" memes? The absurdly long paper strips?

JORDAN: Oh, I've had receipts longer than my Christmas tree. It’s their weirdest legacy.

ALEX: It’s a symbol of their data collection. Those receipts are fueled by loyalty programs that track exactly what you buy, giving them a data profile on millions of patients. It’s a total healthcare ecosystem built on top of a retail foundation.

[OUTRO]

JORDAN: This feels like more than a pharmacy. What’s the one thing to remember about CVS Health?

ALEX: They are no longer a store that sells products; they are a massive healthcare gatekeeper that controls the insurance, the middleman, and the provider for millions of people.

JORDAN: That's Wikipodia — every story, on demand. Search your next topic at wikipodia.ai

Discover how two French brothers invented wireline logging and built SLB into the world's largest oilfield services company, now pivoting to a green future.

[INTRO]

ALEX: Imagine you’re standing on the surface of the Earth, and you need to know exactly what’s happening five miles beneath your feet—without digging a giant hole first. In 1927, two brothers figured out how to give the Earth an EKG, and in doing so, they created a company that now operates in 120 countries and basically runs the global energy grid from the shadows.

JORDAN: Wait, so they can 'see' through rock? That sounds less like geology and more like high-tech clairvoyance. Who are we talking about?

ALEX: We’re talking about Schlumberger—now known simply as SLB. They are the biggest company you’ve probably never heard of, and they just underwent a massive rebrand to try and save themselves from the very industry they helped build.

[CHAPTER 1 - Origin]

ALEX: This all starts with Conrad and Marcel Schlumberger. Conrad was the dreamer, a physics professor in Paris who had this wild idea: what if we use electricity to map what’s underground? Metals and rocks conduct electricity differently, so he thought he could use that 'resistivity' to find minerals.

JORDAN: So he's essentially using the Earth as a giant circuit board? Did it actually work or was he just shocking worms?

ALEX: It worked brilliantly. In 1927, in a small field in France, they performed the first 'wireline log.' They lowered an electrical probe into a well on a long cable, and as they pulled it up, a needle on a chart recorded the electrical resistance of the strata. It was the first time humans had a continuous record of the subsurface without bringing up physical rock core samples.

JORDAN: I bet the oil companies went nuclear for that. Before this, they were basically just drilling and praying, right?

ALEX: Exactly. This turned 'wildcatting' into a data science. By 1934, the brothers moved their headquarters to Houston, Texas, because that’s where the black gold was. But here's the kicker: they weren't interested in owning the oil. They wanted to own the data about the oil.

[CHAPTER 2 - Core Story]

ALEX: For the next fifty years, Schlumberger became the gold standard. They didn't just provide a service; they became the technology gatekeepers. If you wanted to drill a complex well, you had to call them. They even had their own legendary research center in Connecticut designed by the famous architect Philip Johnson.

JORDAN: Okay, but if they’re so successful, why did they try to buy a computer chip company and a semiconductor business in the 70s? That sounds like a classic case of 'we have too much money and no idea what to do with it.'

ALEX: That was the Jean Riboud era. Riboud was this charismatic, art-collecting CEO who led the company for twenty years. He famously said, 'We are selling technology, not oil.' He bought Fairchild Semiconductor because he realized that to process geological data faster, they needed to own the hardware. It was a massive failure financially, but it proved one thing: Schlumberger saw themselves as a tech company first, and an energy company second.

JORDAN: A tech company that occasionally gets its hands greasy. But they didn't just stay in France and Texas; they are everywhere. Isn't that a geopolitical nightmare?

ALEX: Total nightmare. Because they're the only ones with the best tech, they end up in some hot water. In 2015, they had to pay a $232 million fine for violating U.S. sanctions in Iran and Sudan. Most recently, they faced massive pressure to leave Russia after the invasion of Ukraine. When you’re the invisible giant that provides the 'brains' for oil production, you can’t really hide when things go south.

JORDAN: So they're the people you call when the job is too hard for everyone else, but that means they're also the ones caught in the crossfire when the world stops getting along.

[CHAPTER 3 - Why It Matters]

ALEX: That brings us to right now. In 2022, they officially changed their name from Schlumberger to just SLB. They’ve realized that being the world’s best oil-prospecting company is a liability in a world moving toward net-zero emissions.

JORDAN: Is 'SLB' just a fresh coat of paint, or are they actually doing something different? It’s hard to believe a company built on fossil fuels is suddenly going green.

ALEX: It’s a massive pivot. They’re taking that same 'subsurface' expertise they used for oil and applying it to Carbon Capture and Geothermal energy. If you want to pump CO2 back into the ground and keep it there forever, you need the same mapping technology they invented in 1927. They're trying to prove that the 'architects of the oil age' can become the 'architects of the energy transition.'

JORDAN: It’s a hell of a gamble. They’re basically betting that their math is more valuable than the commodity they’ve spent a century chasing.

[OUTRO]

JORDAN: So, if I’m at a dinner party and someone mentions the global energy transition, what’s the one thing I should remember about SLB?

ALEX: Remember that SLB doesn't just drill for oil; they own the digital map of the world beneath our feet, and that map is the key to both the fossil fuel past and the green energy future.

JORDAN: That’s Wikipodia — every story, on demand. Search your next topic at wikipodia.ai

Meet American Tower, the $100 billion giant that owns the steel behind your 5G signal and the 'edge' of the future internet.

[INTRO]

ALEX: Jordan, Every time you look at your phone to check a map or stream a video, you are paying rent to a company you’ve likely never heard of.

JORDAN: Wait, I pay my carrier. Are you saying there's a middleman hiding in my data plan?

ALEX: Exactly. There is a 100-billion-dollar empire called American Tower that owns the actual steel and dirt making your digital life possible, and they have become the world’s most powerful invisible landlord.

JORDAN: So while we’re arguing about which phone is better, these guys are just sitting back and collecting checks for the space on the poles? That's a hell of a business model.

[CHAPTER 1 - Origin]

ALEX: It actually started as a side hustle for a radio company. In 1995, American Radio Systems owned a bunch of stations, and they had these broadcast towers just sitting there.

JORDAN: Right, because you need the height for the signal. But back then, was it just for FM radio and local news?

ALEX: Mostly, yeah. They formed American Tower as a subsidiary just to manage those assets. But then, in 1998, the parent company merged with CBS, and they decided to spin the tower business off into its own thing.

JORDAN: That seems like perfect timing. 1998 is right when everyone started carrying those bulky Nokia bricks in their pockets.

ALEX: It was the ultimate "right place, right time" moment. They realized that instead of a tower just holding up one radio antenna, they could lease space to four or five different cellular companies at once.

JORDAN: It’s like an apartment building, but for antennas. One piece of land, multiple tenants paying rent.

ALEX: That’s the core of the business. The world went from needing a few big radio sticks to needing tens of thousands of cell towers, and American Tower was ready to build the forest.

[CHAPTER 2 - Core Story]

JORDAN: So they started with radio towers. How do they go from a radio spinoff to a global behemoth owning 225,000 sites?

ALEX: They played a massive game of Monopoly. Throughout the 2000s, they didn't just build towers; they bought them in bulk.

JORDAN: Buying them from who? I assumed the phone companies owned their own equipment.

ALEX: They used to! But Verizon and AT&T eventually realized that maintaining thousands of steel structures is a headache. In 2015, American Tower pulled off a massive deal with Verizon, paying five billion dollars just to take over the rights to 11,000 of their towers.

JORDAN: So the carriers get a huge pile of cash, and American Tower gets a guaranteed tenant for decades. But wait, if they own the tower, they can put Verizon’s competitors on the same pole, right?

ALEX: That is the magic of their math. The cost to keep a tower standing is basically the same whether there’s one antenna on it or five. When they add a second or third carrier to a tower, almost every dollar of that new rent is pure profit.

JORDAN: That sounds like a money-printing machine. Is there any catch?

ALEX: The catch is the debt. To buy all these towers across five continents—including huge expansions into India, Mexico, and Europe—they borrowed billions. They even converted the company into a Real Estate Investment Trust, or REIT, in 2012.

JORDAN: A REIT? That’s the tax structure where they have to pay out 90% of their income to shareholders, right?

ALEX: Correct. It turned them into a favorite for Wall Street investors who wanted a steady dividend. But it also meant they had to keep growing to keep the engine running. They went deep into India, owning 77,000 towers there at one point.

JORDAN: That sounds risky. Operating in emerging markets globally has to be way messier than a suburban tower in Ohio.

ALEX: It was. They faced currency swings and carrier bankruptcies. In 2024, they actually decided to sell off their entire Indian operation for 2.5 billion dollars just to simplify their books and pay down some of that massive debt.

[CHAPTER 3 - Why It Matters]

JORDAN: So if they’re pulling back from places like India, what’s the next move? Is the world finally full of towers?

ALEX: Not even close. We’re moving into the era of 5G and Artificial Intelligence, and that requires a different kind of infrastructure. In 2021, they dropped ten billion dollars to buy a data center company called CoreSite.

JORDAN: Wait, why does a tower company want data centers? Those are big warehouses full of servers, not poles in a field.

ALEX: They’re betting on something called "Edge Computing." The idea is that for things like self-driving cars or instant AI, the data can't travel all the way to a giant server farm in Virginia and back. It needs to be processed closer to you.

JORDAN: So they want to put mini-data centers right at the base of the cell towers they already own?

ALEX: Exactly. They want to be the physical backbone of the entire internet, not just the guy holding the antenna. They are moving from steel to silicon.

JORDAN: It’s wild that one company has that much control over the physical reality of our digital lives. If they disappear, the whole grid goes dark.

ALEX: They are the ultimate "picks and shovels" play. They don't care if you use an iPhone or an Android, or if you’re on T-Mobile or Verizon. As long as you’re using data, you’re using their ground.

[OUTRO]

JORDAN: Okay, Alex, what’s the one thing to remember about American Tower?

ALEX: They are the world’s most essential landlord, owning the physical intersections where the wireless world meets the wired internet.

JORDAN: That’s Wikipodia — every story, on demand. Search your next topic at wikipodia.ai

Discover how Amgen turned recombinant DNA into a multi-billion dollar empire, survived a massive safety crisis, and fought the FTC for its future.

[INTRO]

ALEX: In 1980, a group of scientists in California started a company that experimented with using genetics to make chickens grow faster and create better dye for blue jeans.

JORDAN: Wait, they were trying to engineer better denim? That’s a far cry from a multi-billion dollar pharmaceutical giant.

ALEX: It really is, but that company was Amgen, and they eventually pivoted to a project codenamed "Project Alpha." They successfully cloned a human gene that triggers the production of red blood cells, essentially creating a way to manufacture blood in a lab.

JORDAN: That sounds like science fiction. So they went from blue jeans to literally printing life-saving proteins?

[CHAPTER 1 - Origin]

ALEX: Precisely. Amgen, which stands for Applied Molecular Genetics, was born during the wild west of the early biotech era. Their first CEO, George Rathmann, was a charismatic chemist who refused to let Amgen become just another boring drug company; he wanted to hunt for "blockbusters."

JORDAN: "Blockbusters" sounds like a movie industry term. What does that mean in the world of medicine?

ALEX: In pharma, a blockbuster is a drug that generates over a billion dollars in annual sales. Amgen found theirs in 1983 when a scientist named Fu-Kuen Lin isolated the gene for erythropoietin, or EPO.

JORDAN: EPO... I’ve heard of that in sports. Isn't that what cyclists use to cheat?

ALEX: It is, because it boosts red blood cells, giving you more oxygen and endurance. But for patients with kidney failure who were dangerously anemic, it was a miracle that meant they didn't need constant blood transfusions anymore.

JORDAN: So they have the miracle gene. Was it smooth sailing from there?

ALEX: Not even close. Amgen spent the late 80s locked in a brutal "patent war" with Genentech, who had their own version of the protein. Amgen eventually won in court, securing a monopoly on the U.S. dialysis market that turned them into a household name in the investment world.

[CHAPTER 2 - Core Story]

ALEX: By the 90s, Amgen was the king of biotech. They released Epogen and then Neupogen, which helps cancer patients fight off infections after chemo. These two drugs were like money-printing machines.

JORDAN: Okay, but usually when a company is that successful, something goes wrong. Is there a catch?

ALEX: The catch came in the mid-2000s, and it almost sank the company. Amgen had pushed a longer-acting version of the drug called Aranesp, but new studies suddenly linked high doses of these anemia drugs to increased risks of heart attacks, strokes, and even faster tumor growth.

JORDAN: Wait, the drugs meant to help cancer patients were actually making their tumors grow faster?

ALEX: In some cases, yes. It was a massive safety crisis. The FDA slapped a "black box" warning—their most severe caution—on the labels in 2007.

JORDAN: I’m guessing investors panicked. How do you recover from a "black box" warning on your best-selling product?

ALEX: You pivot. Hard. Amgen realized they couldn't rely on just two or three miracle drugs anymore. They started buying their way into new fields.

JORDAN: They went on a shopping spree?

ALEX: A massive one. They spent sixteen billion dollars to buy Immunex to get into immunology. Later, they spent ten billion on Onyx for cancer drugs. They were essentially reinventing themselves every decade to stay ahead of the lawsuits and the competition.

JORDAN: Did they ever get back to that "miracle science" they started with, or did they just become a giant holding company?

ALEX: They did both. In 2020, they achieved a scientific breakthrough with a drug called Lumakras. For forty years, scientists thought a specific cancer-causing protein called KRAS was "undruggable"—literally impossible to target—but Amgen finally cracked the code.

[CHAPTER 3 - Why It Matters]

JORDAN: So they're back to being the science pioneers. But with drug prices being such a hot topic, how is a giant like Amgen viewed today?

ALEX: It's complicated. They are currently a leader in "biosimilars," which are basically generic versions of complex biologic drugs. They’re trying to lower costs while also defending their own high prices on older drugs.

JORDAN: It sounds like they are fighting a war on two fronts: trying to be the innovator and the cost-cutter at the same time.

ALEX: Exactly. And the government is watching closely. In 2023, the FTC tried to block Amgen's twenty-eight billion dollar purchase of Horizon Therapeutics. The government was worried Amgen would use its massive portfolio to bully insurance companies into favoring their new rare-disease drugs.

JORDAN: Twenty-eight billion? That’s a huge bet on rare diseases. Did the deal go through?

ALEX: It did, but only after Amgen promised not to use those "strong-arm" tactics. It shows that even for a pioneer, the rules of the game have changed. They aren't just a startup in a garage anymore; they are a central pillar of the global healthcare infrastructure.

[OUTRO]

JORDAN: This company has survived patent wars, a safety meltdown, and the FTC. What’s the one thing to remember about Amgen?

ALEX: Amgen proved that you could turn the building blocks of life into a global industry, but their story shows that being a pioneer means you'll eventually have to answer for the risks of that innovation.

JORDAN: That’s Wikipodia — every story, on demand. Search your next topic at wikipodia.ai.

Explore the life of Walt Disney, from his early bankruptcies and losing Oswald the Rabbit to building a global empire and the 'Experimental Prototype' city.

[INTRO]

ALEX: If you walk past the firehouse on Main Street in Disneyland, you’ll notice a small lamp kept perpetually lit in a second-story window. It’s a tribute to the man who lived there, a billionaire who held more Oscars than anyone in history, yet spent his nights in a tiny apartment above a fake fire station just to watch people enjoy his creation.

JORDAN: Wait, he actually lived in the park? That sounds like the ultimate corporate flex, but also a little intense. Was he just obsessed with the bottom line or the magic?

ALEX: For Walt Disney, there was no difference between the two. He was a man who turned personal betrayals into the world’s most famous mouse and gambled his entire company on a ‘folly’ that everyone said would ruin him.

JORDAN: I feel like we only know the 'Uncle Walt' version—the guy in the suit introducing cartoons. But you’re saying there’s a much grittier story behind the ears?

[CHAPTER 1 - Origin]

ALEX: Absolutely. To understand the grit, you have to go back to Kansas City in 1922. Walt was just 21 when he started Laugh-O-Gram Studio. He was talented, but he was a terrible businessman. By 1923, he was literally bankrupt.

JORDAN: So he wasn't always the golden boy of Hollywood. What was the 'break glass in case of emergency' plan?

ALEX: He hopped a train to California with forty dollars in his pocket and a finished reel of a film called the Alice Comedies. He teamed up with his brother Roy, who became the financial anchor of what they called the Disney Brothers Studio. Roy handled the books so Walt could handle the dreams.

JORDAN: Every creative needs a 'Roy.' But they didn't start with Mickey, right? I've heard there was another animal in the mix first.

ALEX: Oswald the Lucky Rabbit. This is the first major turning point. Oswald was a massive hit for Universal Studios in 1927. But when Walt went to negotiate for more money, he found out the distributor had basically legally hijacked the character and hired away almost all of Walt’s animators.

JORDAN: That’s cold. He lost everything because he didn't read the fine print?

ALEX: Exactly. On the train ride back from that disastrous meeting, Walt realized he had to own everything he created. He and his loyal animator, Ub Iwerks, started sketching a new character. They shortened the ears, rounded the nose, and Mickey Mouse was born out of pure spite and necessity.

[CHAPTER 2 - Core Story]

JORDAN: Okay, so Mickey is the comeback story. But cartoons were everywhere back then. How did Disney make them must-see TV before TV even existed?

ALEX: He bet on tech. In 1928, 'Steamboat Willie' became a sensation because it used synchronized sound—a massive technical leap. Then in 1932, he used a three-strip Technicolor process for 'Flowers and Trees,' winning the first-ever Oscar for a short film.

JORDAN: Tech is expensive, though. Was the studio actually making money or just winning trophies?

ALEX: They were constantly on the edge. The industry actually called his next project 'Disney’s Folly.' He wanted to make a feature-length animated film. No one thought an audience would sit through 80 minutes of drawings.

JORDAN: I’m guessing this is 'Snow White'?

ALEX: Yes. Even his brother Roy told him to kill it. It cost $1.5 million—an insane amount during the Great Depression. But when it premiered in 1937, it made $8 million in its first run. It proved that animation wasn't just for kids’ shorts; it was cinema.

JORDAN: So he’s the king of the world, right? Snow White is a hit, he’s winning Oscars left and right. Where’s the catch?

ALEX: The catch was his management style. Walt viewed the studio as a family where he was the father figure, but in 1941, reality hit in the form of a massive animators' strike. They wanted better pay and credit. Walt felt personally betrayed—he even thought it was a communist plot.

JORDAN: That sounds like it would shatter the 'wholesome' image pretty quickly.

ALEX: It did. It fractured the studio culture forever. He stopped being 'one of the guys' and became the Boss. But he didn't slow down. He pivoted into live-action like 'Mary Poppins' and then turned his eyes to the physical world.

JORDAN: You mean Disneyland. But why a park? He already had the movies.

ALEX: He hated the dirty, seedy amusement parks of the era. He wanted a controlled environment. He used his television show—which was basically a weekly commercial—to fund and market 'Project X.' When Disneyland opened in 1955, it wasn't just a place with rides; it was the first 'immersive experience.'

[CHAPTER 3 - Why It Matters]

JORDAN: We see Disney logos everywhere today, but when you look at the man himself, what’s the real legacy? Is it just the cartoons?

ALEX: It’s the model of 'synergy.' Walt was the first to realize that a movie character could be a toy, a TV star, a comic book, and a theme park attraction all at once. He built a self-reinforcing loop of intellectual property that every media company now tries to copy.

JORDAN: It’s not all sunshine and rainbows, though. He’s been a lightning rod for controversy since he died, right?

ALEX: Very much so. From the 1941 strike to the 'outdated cultural depictions' in films like 'Song of the South' or 'Dumbo,' his work is a time capsule of both American innovation and its historical prejudices. He was a perfectionist who wanted to control every frame of film and every inch of his parks.

JORDAN: His final dream was the weirdest one, though. EPCOT. It wasn't supposed to be a theme park with a giant golf ball, was it?

ALEX: No, it was intended to be a literal city. The Experimental Prototype Community of Tomorrow. A functioning utopian society where people would actually live and work using the latest technology. He died of lung cancer in 1966 before he could build it, and the company turned it into a permanent World’s Fair instead.

[OUTRO]

JORDAN: It’s wild that the guy who started with a bankrupt rabbit-stealing disaster ended up trying to design the future of human cities. What’s the one thing to remember about Walt Disney?

ALEX: Walt Disney proved that if you own your ideas and obsess over the details, you don't just tell stories—you create the world people want to live in.

JORDAN: That’s Wikipodia — every story, on demand. Search your next topic at wikipodia.ai

Discover how a niche DVD-by-mail service survived a Blockbuster rejection to become a global streaming titan and the king of binge-watching.

[INTRO]

ALEX: In the year 2000, the CEO of Blockbuster was offered the chance to buy a struggling little startup called Netflix for just $50 million, and he reportedly laughed the founders out of the room.

JORDAN: Ouch. I'm guessing that ranks right up there with the record label that passed on the Beatles?

ALEX: Exactly. Today, Blockbuster is a memory, and Netflix is a global empire that fundamentally changed how humans consume stories.

JORDAN: So, how did a company that started with red envelopes and postage stamps end up making the world's most-watched TV shows?

[CHAPTER 1 - Origin]

ALEX: It all started in 1997 with a computer scientist named Reed Hastings and a marketing expert named Marc Randolph. The legendary story is that Hastings got a forty-dollar late fee for a VHS of *Apollo 13* and decided there had to be a better way.

JORDAN: Wait, is that actually true? Because that sounds like a very polished PR story.

ALEX: You've got a good nose for fiction, Jordan. Randolph actually calls that a "convenient myth." In reality, they just wanted to apply Amazon's e-commerce model to something portable, and they landed on DVDs because they were light and cheap to mail.

JORDAN: Smart. But mailing a disc and waiting three days for it to arrive doesn't exactly scream "industry disruptor."

ALEX: Not at first. But in 1999, they introduced a monthly subscription with no due dates and no late fees. That was the 'Aha!' moment that turned movie renting from a chore into a hobby.

JORDAN: And that's when they tried to sell to Blockbuster, right?

ALEX: Yes. They were bleeding cash and had only 300,000 subscribers. Blockbuster viewed them as a tiny, niche joke. So, Netflix went home, went public in 2002, and started building a secret weapon: an algorithm to predict exactly what you wanted to watch next.

[CHAPTER 2 - Core Story]

ALEX: By 2007, Netflix saw the writing on the wall for physical discs. High-speed internet was finally reaching homes, so they launched "Watch Now"—their first streaming service.

JORDAN: I remember that! The library was tiny back then. It was mostly random documentaries and old B-movies.

ALEX: It was, but it grew fast. So fast, in fact, that the big Hollywood studios started getting nervous. They realized they were licensing their best content to a company that was slowly killing them.

JORDAN: So the studios started pulling their shows back? Like a digital embargo?

ALEX: Precisely. Netflix realized that if they didn't own the content, they were dead. They hired Ted Sarandos to lead a massive shift into original production. Their first big swing wasn't actually *House of Cards*—it was a show called *Lilyhammer*—but *House of Cards* in 2013 was the one that changed everything.

JORDAN: Because they released the whole season at once, right? No waiting a week for the next episode?

ALEX: Exactly. They used their data to see that people loved Kevin Spacey and director David Fincher, so they skipped the pilot process and ordered two full seasons for $100 million. By dropping every episode on day one, they basically invented and institutionalized "binge-watching."

JORDAN: It’s a bold move to just hand over a hundred million based on an algorithm. Did it actually work outside the US?

ALEX: It worked better than anyone expected. In 2016, Reed Hastings stood on a stage and announced they were going live in 130 countries simultaneously. They started producing shows in local languages—like *Money Heist* in Spain and *Squid Game* in South Korea—which became global phenomena. They weren't just a tech company anymore; they were the world’s biggest studio.

[CHAPTER 3 - Why It Matters]

JORDAN: So they won. But now I feel like every time I open my phone, there’s a new streaming service. Is the party over?

ALEX: The "Streaming Wars" hit hard in 2022. For the first time in a decade, Netflix actually lost subscribers. Disney, HBO, and Amazon all jumped into the ring, and the market got crowded.

JORDAN: Is that why I’m suddenly seeing ads on a service I pay for?

ALEX: It is. After years of promising they would never show ads or stop people from sharing passwords, Netflix had to pivot again. They launched a cheaper ad-supported tier and started cracking down on friends sharing accounts to squeeze more revenue out of the people already watching.

JORDAN: It feels like they’re becoming the very thing they set out to destroy—traditional cable TV.

ALEX: In some ways, yes. But they're also expanding into mobile gaming and live events. They even shut down their original DVD-by-mail service in 2023, officially closing the chapter on the red envelopes.

JORDAN: It’s wild that they’re willing to kill their original business model just to stay ahead. Most companies would just ride it into the ground.

ALEX: That’s the Netflix DNA. Their internal culture is famous for something called "Freedom and Responsibility." They pay top-of-market salaries but have a "radical candor" policy where only "A-players" keep their jobs. It’s high-pressure, but it’s what allowed them to pivot from mail to streaming to global production without flinching.

[OUTRO]

JORDAN: Alright, Alex, what’s the one thing we should remember about Netflix?

ALEX: Remember that Netflix succeeded by being more willing to disrupt itself than its competitors were willing to adapt.

JORDAN: That’s Wikipodia — every story, on demand. Search your next topic at wikipodia.ai

Discover how Amgen turned basic biology into a multibillion-dollar empire, navigating massive medical breakthroughs and intense legal scandals.

[INTRO]

ALEX: In the early 1980s, a group of scientists in a California office park tried to find a single human gene that was basically a needle in a haystack—and when they found it, they launched a 150-billion-dollar industry.
JORDAN: Wait, so this wasn't just a tech startup? They were literally coding with human DNA?
ALEX: Exactly. This is the story of Amgen, the company that turned "recombinant DNA" from a sci-fi concept into some of the best-selling drugs in history.
JORDAN: But I’m guessing billionaire scientists and "miracle drugs" come with a pretty heavy side of legal drama?
ALEX: More like a 762-million-dollar side of drama. Today, we’re looking at Amgen: the pioneer, the powerhouse, and the poster child for the messy business of biotech.

[CHAPTER 1 - Origin]

ALEX: It’s 1980 in Thousand Oaks, California. A venture capitalist named William Bowes teams up with a scientist named Winston Salser to start "Applied Molecular Genetics."
JORDAN: That’s a mouthful. I can see why they shortened it to Amgen.
ALEX: Definitely. They recruited George Rathmann from Abbott Labs to be the first CEO, and the culture was so academic and intense, people called it "Biotech Camelot."
JORDAN: Camelot? Were they looking for the Holy Grail or just trying to pay the rent?
ALEX: A bit of both. At the time, biotech was a wild frontier. They weren't making pills from chemicals in a lab; they were trying to hijack living cells to manufacture human proteins.
JORDAN: That sounds incredibly expensive and slightly terrifying for 1980.
ALEX: It was. Their early office was so modest it was once described as looking like a place where people go to get a cheap haircut. But inside, a scientist named Fu-Kuen Lin was doing something revolutionary: he was trying to clone the gene for erythropoietin, or EPO.
JORDAN: I know that name—isn't that the stuff athletes use for blood doping?
ALEX: It became that, but Lin’s goal was humanitarian. EPO is a hormone that tells your body to make red blood cells. If you have kidney failure, you stop making it and become severely anemic. Finding that one gene out of the entire human genome was the breakthrough that saved the company.

[CHAPTER 2 - Core Story]

ALEX: In 1989, the FDA approves Amgen's first blockbuster, Epogen. Suddenly, dialysis patients who used to need constant blood transfusions could just take a shot.
JORDAN: I'm guessing the stock price didn't stay "cheap haircut" level for long?
ALEX: It exploded. They followed it up in 1991 with Neupogen, which helps cancer patients rebuild their immune systems after chemo. Amgen became the first biotech company to join the Fortune 500.
JORDAN: So they’re the heroes of the industry. Where does it start to go off the rails?
ALEX: It comes down to the classic struggle between science and sales. Once you have a blockbuster drug, the pressure to keep growth high is immense.
JORDAN: Let me guess: they started selling it for things it wasn't supposed to treat?
ALEX: Precisely. In the mid-2000s, Amgen began aggressively pushing a newer version of their anemia drug, Aranesp, for "off-label" uses in cancer patients. They were encouraging doctors to use higher doses than recommended.
JORDAN: That sounds like a massive safety risk. Did it backfire?
ALEX: Terribly. Studies started showing that these high doses were actually linked to increased risks of heart attacks and even tumor growth in some patients. In 2012, Amgen pleaded guilty to a criminal charge of misbranding and paid a 762-million-dollar settlement.
JORDAN: That’s a huge hit. Did it break them?
ALEX: No, they actually doubled down on a new strategy: growth through acquisition. They bought Immunex for 16 billion dollars just to get their hands on Enbrel, a drug for rheumatoid arthritis. They basically shifted from a scrappy startup to a giant that buys its way into new markets.
JORDAN: So they stopped being the guys finding needles in haystacks and started being the guys who just buy the whole farm.

[CHAPTER 3 - Why It Matters]

ALEX: Amgen matters because they proved that "Biology First" works as a business model. They didn't just make drugs; they mastered biomanufacturing—building massive, high-tech factories that produce complex proteins at a scale no one thought possible.
JORDAN: But aren't they also the ones famously fighting to keep drug prices high?
ALEX: That’s the flip side. They are masters of the "patent thicket," using legal maneuvers to block cheaper generic versions of their drugs for years. Senator Bernie Sanders once pointed out that the price of their drug Enbrel rose 500 percent since it launched.
JORDAN: So they pioneered the science, but they also pioneered the high-stakes legal games we see in healthcare today.
ALEX: Exactly. They’ve even started making "biosimilars" themselves—basically making their own versions of other companies' off-patent drugs. They’ve gone from the outsiders disrupting Big Pharma to being the definition of Big Pharma.
JORDAN: It’s a total 180. They’re now the gatekeepers of the very technology they invented.
ALEX: And with their recent 27-billion-dollar purchase of Horizon Therapeutics, they’re showing no signs of slowing down. They’ve successfully navigated from a tiny lab in Thousand Oaks to a global entity that influences almost every part of the modern pharmacy.

[OUTRO]

JORDAN: Alright, Alex, what’s the one thing we should remember about Amgen?
ALEX: Amgen proved that engineering biology could create a multibillion-dollar industry, but it also showed that when life-saving science meets Wall Street, the ethics can get as complex as the DNA itself.
JORDAN: That’s Wikipodia — every story, on demand. Search your next topic at wikipodia.ai.

Discover how a radio spinoff became a global giant, owning the 'invisible' infrastructure behind your smartphone and the future of 5G.

[INTRO]

ALEX: Most people think their cell phone signal comes from a satellite or some invisible cloud, but it actually depends on a massive empire of 'dumb steel' owned by a company you’ve probably never heard of.

JORDAN: Let me guess, some tech giant in Silicon Valley?

ALEX: Not even close. It’s a real estate company called American Tower that owns over 220,000 structures worldwide, and they are essentially the 'landlords of the skies.'

JORDAN: Wait, so they don’t actually provide the phone service? They just own the physical poles the antennas sit on?

ALEX: Exactly. They’ve turned basic vertical real estate into a global powerhouse worth billions, and today we’re looking at how they became the invisible backbone of the internet.

[CHAPTER 1 - Origin]

ALEX: To understand American Tower, you have to go back to 1995. At the time, they were just a small division of a company called American Radio Systems.

JORDAN: So they started with radio towers? That feels very 'old school' for a company powering 5G.

ALEX: It was! Their only job was managing towers for their parent company's radio stations. But in 1998, a huge shift happened: CBS bought the radio stations, but they didn’t want the towers.

JORDAN: They just left the towers behind? Why?

ALEX: They saw them as a burden—expensive, clunky pieces of metal that needed constant maintenance. American Tower was spun off as its own independent company, and they realized something brilliant: the cell phone revolution was just beginning.

JORDAN: So while everyone else was fighting over who had the best phone, American Tower realized everyone would need a place to put their equipment?

ALEX: Preciseley. They weren't interested in being the software; they wanted to be the ground the software stood on.

[CHAPTER 2 - Core Story]

ALEX: The business model they perfected is incredibly simple but wildly profitable. It’s called 'Shared Passive Infrastructure.'

JORDAN: That sounds like corporate-speak for 'we don't do much.' What does it actually mean?

ALEX: Think of a tower like an apartment building. American Tower builds the skyscraper—the steel structure—and then they lease 'floors' or space on that tower to tenants like Verizon, AT&T, and T-Mobile.

JORDAN: So competitors are literally living in the same house?

ALEX: Yes! And that’s the genius of it. The first tenant helps pay off the cost of building the tower, but the second, third, and fourth tenants are almost pure profit. The cost to add them is tiny because the tower is already there.

JORDAN: But what stops a carrier from just leaving if they find a cheaper 'apartment'?

ALEX: The contracts are the secret sauce. These are 5-to-10-year, non-cancellable leases with built-in rent increases every single year.

JORDAN: It’s like a landlord’s dream. You never have to find new tenants, and the rent always goes up.

ALEX: It gets even better. In 2012, they officially became a REIT, or a Real Estate Investment Trust. This changed their DNA. Because they are legally classified as a real estate company, they don't pay corporate income tax as long as they give 90% of their profits back to shareholders as dividends.

JORDAN: So they have a tax-free money machine. What did they do with all that extra cash?

ALEX: They went on a global shopping spree. They bought thousands of towers in Brazil, India, Germany, and Nigeria. They stopped being a US company and started becoming a global utility.

JORDAN: But it can't all be smooth sailing. I imagine building a giant steel pole in the middle of a neighborhood doesn't exactly make you popular with the residents.

ALEX: You’re right—NIMBYism, or 'Not In My Backyard,' is a huge hurdle. People hate the way towers look, and local communities often fight tooth and nail to block them. That actually makes existing towers even more valuable, because nobody can build a new one nearby.

[CHAPTER 3 - Why It Matters]

JORDAN: Okay, so they own most of the towers. But we're moving toward a world with data centers and fiber optics. Is 'dumb steel' still a good bet?

ALEX: That’s the big question they’re answering right now. In 2021, they spent 10 billion dollars to buy a company called CoreSite, which owns massive data centers.

JORDAN: So they're moving from the 'sky' into the 'cloud' for real.

ALEX: Exactly. They are betting that as 5G takes off, the distance between the tower and the computer processing the data needs to shrink. They want to own the entire journey of your data—from the antenna on the tower to the server in the basement.

JORDAN: It’s a pivot from being a landlord of steel to being a landlord of the digital age.

ALEX: It really is. They’ve essentially built a toll booth on the information superhighway. Every time you stream a video or send a text, a tiny fraction of a cent is basically flowing toward their bottom line.

[OUTRO]

JORDAN: What’s the one thing to remember about American Tower?

ALEX: They proved that in a gold rush, you don't want to be the one digging for gold; you want to be the one owning the land where the gold is buried.

JORDAN: That’s Wikipodia — every story, on demand. Search your next topic at wikipodia.ai

Explore the high-stakes life of Walt Disney, from his early bankruptcy and losing Oswald the Rabbit to building a global empire and the utopian dream of EPCOT.

[INTRO]

ALEX: Most people think of Walt Disney as a grandfatherly storyteller, but he actually holds a world record that has nothing to do with theme parks. He won 26 Academy Awards—more than anyone else in history—and he did it by betting his entire life’s savings on a movie everyone called 'Disney's Folly.'

JORDAN: Wait, 26 Oscars? That feels like he was playing the game on easy mode. Was he actually that good, or did he just have the best PR team in Hollywood?

ALEX: It was definitely not easy mode. Before the Oscars and the Magic Kingdom, he was a high school dropout who went bankrupt and had his first hit character literally stolen from him. Today, we’re looking at the man who built an empire on the back of a mouse, and the high-stakes gambles that almost ruined him at every turn.

[CHAPTER 1 - Origin]

ALEX: To understand Walt, you have to look at 1920s Kansas City. He was 18, working as a commercial illustrator, and he decided to start his own studio called Laugh-O-Gram. It was a total train wreck.

JORDAN: How bad was it? Like, 'sleeping in the office' bad?

ALEX: Exactly that bad. He ended up declaring bankruptcy in 1923 and hopped a train to Hollywood with nothing but a suitcase and forty dollars. He and his brother Roy started a new studio, and they finally caught lightning in a bottle with a character called Oswald the Lucky Rabbit.

JORDAN: Okay, Oswald. I’ve heard of him, but he’s not exactly Mickey Mouse. What happened there?

ALEX: This is the turning point for Walt’s entire personality. In 1927, he went to New York to ask for a raise. Instead, his distributor told him that they had secretly signed away almost all of Walt’s animators and that Universal Pictures—not Walt—owned the rights to Oswald. Walt was essentially fired from his own success.

JORDAN: That is brutal. So he’s in Hollywood, staffless, and his hit character belongs to a conglomerate. What do you even do after a hit like that?

AEX: You vow to never let anyone else own your work ever again. On the train ride back to California, he started sketching a new character. He wanted to call him Mortimer, but his wife Lillian told him the name was too pompous. She suggested Mickey.

[CHAPTER 2 - Core Story]

ALEX: Mickey Mouse wasn’t just a cute drawing; he was a tech demo. In 1928, Walt released *Steamboat Willie*, which featured fully synchronized sound. People had never seen a cartoon 'breathe' and 'react' to music like that before.

JORDAN: So he’s the king of the shorts. But how do you go from a funny mouse to a multi-billion dollar studio?

ALEX: You gamble the house. In the mid-30s, Walt decided to make *Snow White and the Seven Dwarfs*. At the time, nobody thought an audience would sit through a 90-minute cartoon. His own wife and brother told him it would fail. The industry called it 'Disney’s Folly.'

JORDAN: Why was it such a risk? Was it just the length?

ALEX: It was the cost. He spent $1.5 million in 1937 money, which forced him to mortgage his house and take out massive loans. He even hired art instructors to teach his animators how to make human movement look realistic. When it premiered, it grossed $8 million in its first run and basically invented the modern animation industry.

JORDAN: That’s a massive win. But I’m guessing it wasn't all fairy tales and pixie dust behind the scenes.

ALEX: Not at all. The 'happy family' image of the studio shattered in 1941 when his animators went on strike. They wanted union recognition and better pay, and Walt took it deeply personally. He felt betrayed by the people he thought of as his children, and that bitterness stayed with him for the rest of his life.

JORDAN: It sounds like he was becoming a bit of a control freak. Was that why he moved into theme parks?

ALEX: Precisely. In the 1950s, he got tired of the 'dirty' amusement parks of the era. He wanted a place that was perfectly manicured, where he could control every single detail. He pitched Disneyland, but he had to leverage everything—including his life insurance—to get it built. He even started a TV show just to fund the construction.

JORDAN: He’s like the original 'all-in' gambler. Every time he wins, he just bets it all on something bigger.

ALEX: His biggest bet was actually his last one. In the mid-60s, he started buying 27,000 acres of Florida swampland in secret. He didn't just want another park; he wanted to build EPCOT—the Experimental Prototype Community of Tomorrow. He wanted to build a literal city of 20,000 people where there was no unemployment and every piece of tech was cutting-edge.

JORDAN: A functioning city run by a movie studio? That sounds... ambitious. Or maybe a little dystopian?

ALEX: It was definitely a radical vision of urban planning. But he never got to see it. Walt was a heavy smoker, and he died of lung cancer in 1966, just years before the Florida project opened. His brother Roy had to come out of retirement to make sure it was finished.

[CHAPTER 3 - Why It Matters]

JORDAN: So we’ve got the Oscars, the parks, and the mouse. But Disney isn't exactly a beloved figure to everyone today. There’s a lot of baggage there, right?

ALEX: Absolutely. His legacy is a massive duality. On one hand, he pioneered the '12 Principles of Animation' and created the blueprint for how modern media companies operate. On the other hand, the films from his era are full of stereotypes that have forced the company to add content warnings or lock movies like *Song of the South* in a vault forever.

JORDAN: It’s weird to think that the same guy who gave us the childhood magic of *Cinderella* was also making Jim Crow references in *Dumbo*.

ALEX: It’s the paradox of Disney. He was a man of his time who tried to build a future that was perfect and controlled. He turned animation from a novelty into an art form, and he proved that people would pay to escape reality for a few hours. He redefined what 'fun' looks like for the entire world.

[OUTRO]

JORDAN: Okay, Alex. If I have to remember one thing about Walt Disney, what is it?

ALEX: Remember that Walt Disney was a professional risk-taker who built an empire on the one lesson he learned from a stolen rabbit: always own your dreams.

JORDAN: That’s Wikipodia — every story, on demand. Search your next topic at wikipodia.ai.

Discover how Amgen turned basic biology into a multibillion-dollar industry, from the race for EPO to high-stakes legal battles over the future of medicine.

[INTRO]

ALEX: Imagine trying to build a billion-dollar company out of something you can't even see—a tiny protein that tells your body to make blood cells. In 1980, a group of scientists did exactly that, and they called it Amgen.

JORDAN: Wait, so they weren't making pills or chemicals? They were basically hacking human biology?

ALEX: Exactly. They pioneered recombinant DNA technology, which is a fancy way of saying they taught cells how to become tiny factories for medicine. Today, Amgen is a global giant, but their early days were a desperate race against time and rival scientists that nearly broke them.

JORDAN: I love a high-stakes science race. Let’s see how they went from an invisible protein to a pharma powerhouse.

[CHAPTER 1 - Origin]

ALEX: Amgen started in April 1980 under the name 'Applied Molecular Genetics.' The founders, venture capitalist William Bowes and scientist Winston Salser, knew they needed a heavy hitter to lead the charge, so they recruited George Rathmann from Abbott Labs.

JORDAN: And I'm guessing Rathmann wasn't there to play it safe?

ALEX: Not at all. He famously told everyone, 'Amgen is not going to invent a new form of mayonnaise.' He wanted breakthroughs or nothing. In the early 80s, the world of biotech was like the Wild West—investors were pouring money into companies that had great ideas but zero actual products.

JORDAN: So it was all speculative? How do you keep the lights on when you're just... looking at DNA?

ALEX: It was incredibly tense. They went public in June 1983, raising about $42 million, but they were burning through cash. They weren't just competing with nature; they were in a literal sprint against a rival called Genetics Institute to see who could clone the gene for Erythropoietin, or EPO.

[CHAPTER 2 - Core Story]

ALEX: This is where things get cinematic. In 1983, an Amgen scientist named Fu-Kuen Lin finally cracked the code. He successfully isolated the human gene for EPO, which is the hormone that tells your bone marrow to produce red blood cells.

JORDAN: Okay, but why is that worth billions? Who needs more red blood cells?

ALEX: People with chronic kidney failure. At the time, they were often severely anemic and needed constant, painful blood transfusions. Amgen's version, called EPOGEN, changed everything when the FDA approved it in 1989. It didn't just work; it became the first 'blockbuster' biotech drug.

JORDAN: So they hit the jackpot. Did they just sit back and relax after that?

ALEX: Hardly. Just two years later, they launched NEUPOGEN, which helps cancer patients fight off infections during chemo. Suddenly, Amgen had two massive hits. But as they grew into a titan, they started facing the 'Big Pharma' problems: patent wars and controversy.

JORDAN: I knew there’d be a 'but.' What went wrong?

ALEX: In the mid-2000s, studies suggested that using too much of their blood-boosting drugs could actually increase the risk of heart attacks or help tumors grow. The FDA stepped in with 'black-box' warnings, and Amgen's stock price plummeted. They had to lay off thousands of people and rethink their entire strategy.

JORDAN: How do you recover from a hit like that when your main products are under fire?

ALEX: You go shopping. Under CEOs like Kevin Sharer and later Robert Bradway, Amgen started buying its way into new markets. They spent $16 billion on Immunex to get the arthritis drug ENBREL, then eventually $27 billion for Horizon Therapeutics to break into rare diseases.

JORDAN: Twenty-seven billion? That’s not a pivot; that’s an invasion. Was everyone just okay with them buying up the competition?

ALEX: Actually, no. The Federal Trade Commission tried to block the Horizon deal in 2023. They were worried Amgen would use its massive size to bully smaller competitors out of the market through 'bundling' deals. Amgen ultimately won, but it showed that they’re now the establishment everyone is watching.

[CHAPTER 3 - Why It Matters]

ALEX: Today, Amgen isn't just a company; it’s a blueprint. They proved that you could build a massive, profitable business entirely on biologics—medicines grown in living cells rather than mixed in a chemistry lab.

JORDAN: It sounds like they basically forced the rest of the drug industry to stop thinking like chemists and start thinking like biologists.

ALEX: Precisely. They paved the way for the modern map of medicine, from complex cancer therapies to the biosimilars that are slowly making these treatments more affordable. They’ve also pioneered things like 'BiTE' technology, which basically acts like a heat-seeking missile, grabbing a T-cell and dragging it directly to a cancer cell to destroy it.

JORDAN: It’s a long way from the 'not mayonnaise' days.

ALEX: It really is. They’ve transitioned from a high-risk startup to a diversified giant that manages everything from bone health to cardiovascular disease. They still face criticism for high prices and tax strategies, but there's no denying they changed the way we treat human illness.

[OUTRO]

JORDAN: If I’m looking at the big picture, what’s the one thing to remember about Amgen?

ALEX: Amgen proved that 'living' medicine wasn’t just a scientific curiosity—it was a viable industry that could save millions of lives and generate billions of dollars.

JORDAN: That’s Wikipodia — every story, on demand. Search your next topic at wikipodia.ai